WILLIAM MITCH to Biomarkers
This is a "connection" page, showing publications WILLIAM MITCH has written about Biomarkers.
Connection Strength
0.096
-
Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial. Am J Kidney Dis. 2020 02; 75(2):225-234.
Score: 0.021
-
Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675.
Score: 0.019
-
Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients. JCI Insight. 2017 11 16; 2(22).
Score: 0.019
-
Influence of renal function and diet on acid-base status in chronic kidney disease patients. J Ren Nutr. 2009 Mar; 19(2):178-82.
Score: 0.010
-
OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J Am Soc Nephrol. 2008 Nov; 3(6):1741-51.
Score: 0.010
-
Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients. Blood Purif. 2006; 24(5-6):508-16.
Score: 0.009
-
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004 Aug 24; 110(8):921-7.
Score: 0.007